Key result
Higher cardiorespiratory fitness linked to ~7% lower all-cause mortality risk per MET.
Why the study?
Previous studies estimating VO2max from UK Biobank cycle ergometer tests did not account for test individualisation, potentially leading to inaccurate dose-response health relationships.
Does a novel VO2max estimation method improve validity and strengthen the observed dose-response relationship between cardiorespiratory fitness and mortality in the UK Biobank?
Cohort (n=80,259)
Yes
Does a novel VO2max estimation method improve validity and strengthen the observed dose-response relationship between cardiorespiratory fitness and mortality in the UK Biobank?
Answers are grounded in this paper and cite their sources.
A novel, validated method for estimating VO2max from the UK Biobank submaximal cycle test reveals that cardiorespiratory fitness has a twice as strong inverse association with mortality than previously estimated.
Background Cardiorespiratory fitness (CRF) was assessed in UK Biobank (UKB) using heart rate response to a submaximal ramped cycle ergometer test that was individualised for participant characteristics including cardiovascular disease risk. Studies have since explored health associations with CRF by estimating maximal oxygen consumption (VO 2 max) from UKB test data using interpretation methods that have not accounted for this individualisation procedure. Thus, dose-response relationships reported in these studies may be inaccurate. We developed and validated a novel VO 2 max estimation approach that accounts for the UKB test individualisation procedure and compared dose-response relationships with health outcomes between the novel and previous methods. Methods In a cross-over study (n=189), participants completed several UKB tests and VO 2 max was measured. A multilevel modelling framework was developed that combines heart rate response features from the UKB test to estimate VO 2 max. Estimates were compared within participants across UKB test protocols, and with directly measured VO 2 max. Short-term test-retest reliability was assessed in a subsample of participants (n=87). In UKB, we examined associations between estimated CRF and disease endpoints (n=80,259) and compared associations obtained with an unvalidated method. Long-term test-retest reliability was examined (n = 2877). Results Estimated and directly measured VO 2 max were strongly correlated (Pearson’s r range: 0.68 to 0.74) with no mean bias (women bias: −0.8 to 0.4; men bias range: −0.3 to 0.3), outperforming a previous approach for interpreting UKB test data. Agreement between estimated VO 2 max across different test protocols was strong (Pearson’s r range: 0.94 to 0.99). Short- and long-term reliability was also high (lambda=0.91 and 0.80, respectively). All-cause mortality was 7% (95%CI 4-10%, 2686 deaths) lower and CVD mortality 9% (95%CI 3-14%, 858 deaths) lower for every 1-MET difference in fitness, associations twice as strong as determined by previous methods. Conclusions We present a valid and reliable method for estimating CRF in UKB and demonstrate its utility in characterising dose-response relationships with health outcomes. Accounting for the individualisation procedure strengthens observed relationships between CRF and disease and enhances the case for promoting improved fitness in the general population.
No takes yet. Share an insight, caveat, or question.
Gonzales et al. (2020) conducted a cohort in Cardiorespiratory fitness (n=80,259). Cardiorespiratory fitness (per 1-MET increase) vs. Lower fitness was evaluated on All-cause mortality (RRR 7%, 95% CI 4-10%). Every 1-MET difference in estimated cardiorespiratory fitness was associated with a 7% lower risk of all-cause mortality and a 9% lower risk of cardiovascular disease mortality.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: